日本东京女子医科大学和日本电气公司联合研究小组近日从遗传信息的个人差异入手 ,开发出了能预测药物疗效的系统。在用这一系统进行的实验中 ,研究人员发现 ,类风湿性关节炎药物产生的副反应大小因人而异。这一成果据称是药物基因组学领域中的新突破 ,它能帮助患者获得最适合 Japan’s Tokyo Women’s Medical University and Japan Electric Company joint research team recently started from the genetic differences in the individual to start to develop a prediction system of drug efficacy. In the experiments conducted with this system, the researchers found that the magnitude of the side effects of rheumatoid arthritis drugs varies from person to person. This result is said to be a new breakthrough in the field of pharmacogenomics, it can help patients get the most suitable